⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12728373 | 1.00 | — | — | |
| SCHEMBL4322237 | 1.00 | — | — | |
| Cystine SCHEMBL8332360 | 0.85 | PTGS1 (0.50) | — | |
| Cystine SCHEMBL5018669 | 0.85 | PTGS1 (0.50) | — | |
| Cystine SCHEMBL8332356 | 0.85 | PTGS1 (0.50) | — | |
| Cystine SCHEMBL10224 | 0.85 | PTGS1 (0.50) | — | |
| Cystine SCHEMBL10225 | 0.85 | PTGS1 (0.50) | — | |
| Cystine SCHEMBL8332353 | 0.85 | PTGS1 (0.50) | — | |
| Cystine SCHEMBL21114356 | 0.85 | PTGS1 (0.50) | — | |
| Cystine SCHEMBL127805 | 0.85 | PTGS1 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025058054-A1 | METHOD FOR PROMOTING DIFFERENTIATION OF ANIMAL CELL | 味の素株式会社 | 2025-03-20 | — | — | WO | disclosed |
| EP-4342309-A1 | FOUL-ODOR-SUPPRESSING COMPOSITION | AJINOMOTO CO., INC. (JP) | 2024-03-27 | — | — | EP | disclosed |
| EP-4342308-A1 | OFF-FLAVOR SUPPRESSING COMPOSITION | AJINOMOTO CO., INC. (JP) | 2024-03-27 | — | — | EP | disclosed |
| US-20240081380-A1 | OFF-TASTE SUPPRESSING COMPOSITION | AJINOMOTO CO., INC. (JP) | 2024-03-14 | — | — | US | disclosed |
| US-20240081379-A1 | FOUL-ODOR-SUPPRESSING COMPOSITION | AJINOMOTO CO., INC. (JP) | 2024-03-14 | — | — | US | disclosed |
| CN-113735750-B | Method for preparing S-substituent-cysteine derivative by NBS (N-bromosuccinimide) at room temperature | 常州大学 | 2022-07-22 | — | — | CN | disclosed |
| US-20220185867-A1 | MODIFIED HEMOGLOBIN MOLECULES AND USES THEREOF | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2022-06-16 | — | — | US | disclosed |
| CN-113735750-A | Method for preparing S-substituent-cysteine derivative by NBS (N-bromosuccinimide) at room temperature | 常州大学 | 2021-12-03 | — | — | CN | disclosed |
| WO-2020206159-A1 | MODIFIED HEMOGLOBIN MOLECULES AND USES THEREOF | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2020-10-08 | — | — | WO | disclosed |
| US-9080995-B2 | Method for quantitatively analyzing cysteine and cystine and reagent kit for quantitatively analyzing cysteine and cystine | SHISEIDO COMPANY, LTD. (JP) | 2015-07-14 | — | — | US | disclosed |
| WO-2009137251-A2 | CYSTEINE AND CYSTINE BIOISOSTERES TO TREAT SCHIZOPHRENIA AND REDUCE DRUG CRAVINGS | MARQUETTE UNIVERSITY (US) | 2009-11-12 | — | — | WO | disclosed |
| EP-1120435-B1 | APPARATUS AND METHOD FOR PRODUCING RESIN | TEIJIN LTD (JP) | 2004-05-06 | — | — | EP | disclosed |
| US-6562936-B1 | Resin excellent in hydrolysis and heat stability such as a reduction in molecular weight at the time of molding and color retention and moldability such as releasability and transferability, rarely experiences residence deterioration | TEIJIN LIMITED (JP) | 2003-05-13 | — | — | US | disclosed |
| US-6509435-B1 | Heat resistance, stability; moldings | TEIJIN LIMITED (JP) | 2003-01-21 | — | — | US | disclosed |
| EP-1191049-A1 | POLYCARBONATE, PROCESS FOR PRODUCING THE SAME, AND MOLDED ARTICLE THEREOF | TEIJIN LIMITED (JP) | 2002-03-27 | — | — | EP | disclosed |
| EP-1120435-A1 | APPARATUS AND METHOD FOR PRODUCING RESIN | TEIJIN LIMITED (JP) | 2001-08-01 | — | — | EP | disclosed |
| WO-1999021008-A1 | PHARMACEUTICAL GRADE GARLIC | PHARMAPRINT, INC. (US) | 1999-04-29 | — | — | WO | disclosed |
| US-5385933-A | Method for the treatment of cancer by use of the copper complex of S-(methylthio)-DL-homocysteine or the L-enantiomorph thereof | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-01-31 | — | — | US | disclosed |
| US-5124351-A | Containing copper chelate of nitrilotriacetic acid or bis-thiosemicarbazone | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1992-06-23 | — | — | US | disclosed |
| US-4120726-A | Silver-halide emulsion sensitized with an asymmetrical disulfide | VEB FILMFABRIK WOLFEN (DD) | 1978-10-17 | — | — | US | disclosed |